Skip to content
The Policy VaultThe Policy Vault

Xarelto — Medical Mutual

Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) to Reduce the Risk of Recurrence

Reauthorization criteria

  • Response to therapy is required for continuation unless otherwise noted

Approval duration

2 years